FREQUENCY OF PATHOLOGICAL COMPLETE RESPONSE (PCR) IN PATIENTS OF TRIPLE NEGATIVE BREAST CANCER AFTER NEO-ADJUVANT CHEMOTHERAPY

par Zeeshan Ahmed Khan Niazi, Amjad Zafar, Muhammad Wasim Sattar, Waleeja Shamikha, Zaigam Ismail, Muhammad Abbas Khokhar
Publié 2021

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam

par Phung HT, Thi Nguyen H, Nguyen TV, Nguyen TV, Dinh LAT, Nguyen CV
Publié 2020

A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma

par Kunnuru SKR, Thiyagarajan M, Martin Daniel J, Singh K B
Publié 2020

Curative Effect and Survival Assessment Comparing Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin and Cisplatin as Neoadjuvant Therapy for Bladder Cancer: A...

par Tiange Wu, Tiange Wu, Yuqing Wu, Yuqing Wu, Shuqiu Chen, Jianping Wu, Weidong Zhu, Hui Liu, Ming Chen, Ming Chen, Bin Xu, Bin Xu
Publié 2021

A Novel Scoring System for Response of Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer Using Early-Treatment Blood Features Derived From Machine Learning

par Jaesik Kim, Jaesik Kim, Jaesik Kim, Kyung-Ah Sohn, Kyung-Ah Sohn, Jung-Hak Kwak, Min Jung Kim, Min Jung Kim, Seung-Bum Ryoo, Seung-Yong Jeong, Seung-Yong Jeong, Kyu Joo Park, Hyun-Cheol Kang, Eui Kyu Chie, Eui Kyu Chie, Sang-Hyuk Jung, Sang-Hyuk Jung, Sang-Hyuk Jung, Dokyoon Kim, Dokyoon Kim, Ji Won Park, Ji Won Park, Ji Won Park, Ji Won Park
Publié 2021